Literature DB >> 17661210

Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population.

Meenu Jain1, Shaleen Kumar, Puneeta Lal, Anu Tiwari, U C Ghoshal, Balraj Mittal.   

Abstract

Esophageal cancer is multifactorial disease involving environmental and genetic risk factors. Tobacco smoke and alcohol are strong environmental risk factors. N-acetyltransferase 2 (NAT2) is known to metabolize heterocyclic amine carcinogens in tobacco smoke. The purpose of this study was to determine whether genetic polymorphism in the NAT2 and their interaction with environmental factors influence the susceptibility for esophageal cancer. For our study, 126 patients and 164 controls were genotyped for NAT2 2 * 5, 2 * 6 and 2 * 7 polymorphisms using PCR-RFLP method. In a case-control study, NAT2 slow acetylator genotype was not significantly associated with risk of esophageal cancer (OR 1.3, 95%CI = 0.78-2.2, P = 0.28). There was significant linkage disequilibrium between 2 * 5-2 * 6 and 2 * 5-2*7 (P < 0.05). Using expectation maximization algorithm, 6 haplotypes were obtained but none of them revealed any significant contribution to disease susceptibility. In case only analysis, the smokers with rapid acetylator were at slightly higher risk of esophageal cancer (OR 1.3, 95%CI = 0.62-3.0, P = 0.43) which was not statistically significant. NAT2 slow or fast genotypes did not affect the risk of esophageal cancer in patients with alcohol consumption or occupational exposure. These results suggest that NAT2 acetylator genotypes did not influence the susceptibility to esophageal cancer. NAT2 polymorphism did not significantly modulate the cancer risk after interaction with environmental factors like tobacco, alcohol or occupational exposure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661210     DOI: 10.1080/07357900701358074

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  7 in total

1.  Role of novel and GWAS originated PLCE1 genetic variants in susceptibility and prognosis of esophageal cancer patients in northern Indian population.

Authors:  Meenakshi Umar; Rohit Upadhyay; Shaleen Kumar; Uday Chand Ghoshal; Balraj Mittal
Journal:  Tumour Biol       Date:  2014-08-21

2.  Study of NAT2 gene polymorphisms in an Indian population: association with plasma isoniazid concentration in a cohort of tuberculosis patients.

Authors:  Neera Singh; Sudhisha Dubey; Saravanan Chinnaraj; Anil Golani; Anurupa Maitra
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 3.  PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.

Authors:  Ellen M McDonagh; Sotiria Boukouvala; Eleni Aklillu; David W Hein; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-08       Impact factor: 2.089

4.  NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.

Authors:  Marco Matejcic; Matjaz Vogelsang; Yabing Wang; M Iqbal Parker; Iqbal M Parker
Journal:  BMC Cancer       Date:  2015-03-18       Impact factor: 4.430

5.  N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosis.

Authors:  A K Hemanth Kumar; K Ramesh; T Kannan; V Sudha; Hemalatha Haribabu; J Lavanya; Soumya Swaminathan; Geetha Ramachandran
Journal:  Indian J Med Res       Date:  2017-01       Impact factor: 2.375

6.  N-acetyltransferase 2 polymorphisms and risk of esophageal cancer in a Chinese population.

Authors:  Liming Wang; Weifeng Tang; Suocheng Chen; Yangyong Sun; Yu Fan; Yijun Shi; Jingfeng Zhu; Xu Wang; Liang Zheng; Aizhong Shao; Guowen Ding; Chao Liu; Ruiping Liu; Jun Yin; Haiyong Gu
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

7.  Association of common polymorphisms in TNFA, NFkB1 and NFKBIA with risk and prognosis of esophageal squamous cell carcinoma.

Authors:  Meenakshi Umar; Rohit Upadhyay; Shaleen Kumar; Uday Chand Ghoshal; Balraj Mittal
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.